Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/9181
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomford, Nicholas Ekow-
dc.contributor.authorDzobo, Kevin-
dc.contributor.authorYao, Nana Akyaa-
dc.contributor.authorChimusa, Emile-
dc.contributor.authorEvans, Jonathan-
dc.contributor.authorOkai, Emmanuel-
dc.contributor.authorKruszka, Paul-
dc.contributor.authorMuenke, Maximilian-
dc.contributor.authorAwandare, Gordon-
dc.contributor.authorWonkam, Ambroise-
dc.date.accessioned2023-10-10T13:50:55Z-
dc.date.available2023-10-10T13:50:55Z-
dc.date.issued2018-
dc.identifier.urihttp://hdl.handle.net/123456789/9181-
dc.description.abstractCongenital heart defects (CHD) are structural malformations found at birth with a prevalence of 1%. The clinical trajectory of CHD is highly variable and thus in need of robust diagnostics and therapeutics. Major surgical interventions are often required for most CHDs. In Africa, despite advances in life sciences infra- structure and improving education of medical scholars, the limited clinical data suggest that CHD detection and correction are still not at par with the rest of the world. But the toll and genetics of CHDs in Africa has seldom been systematically investigated. We present an expert review on CHD with lessons learned on Africa. We found variable CHD phenotype prevalence in Africa across countries and populations. There are important gaps and paucity in genomic studies of CHD in African populations. Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF. There were no data on epigenomic association of CHD in Africa, however, other studies have shown an altered expression of miR-421 and miR-1233-3p to be associated with TOF and hypermethylation of CpG islands in the promoter of SCO2 gene also been associated with TOF and VSD in children with non-syndromic CHD. These findings signal the urgent need to develop and implement genetic and genomic research on CHD to identify the hereditary and genome–environment inter- actions contributing to CHD. These projected studies would also offer comparisons on CHD pathophysiology between African and other populations worldwide. Genomic research on CHD in Africa should be developed in parallel with next generation technology policy research and responsible innovation frameworks that examine the social and political factors that shape the emergence and societal embedding of new technologies.en_US
dc.language.isoenen_US
dc.publisherOMICS A Journal of Integrative Biologyen_US
dc.subjectcongenital heart defectsen_US
dc.subjectgenomicsen_US
dc.subjectepigenomicsen_US
dc.subjectglobal healthen_US
dc.subjectresponsible innovationen_US
dc.titleGenomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africaen_US
dc.typeArticleen_US
Appears in Collections:School of Allied Health Sciences

Files in This Item:
File Description SizeFormat 
Genomics and Epigenomics of Congenital Heart Defects.pdfMain Article543.78 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.